Cultured enzyme-linked immunospot assay (ELISPOT) enhances detection of low HIV-specific immune responses in exposed seronegative individuals in Kenya

Cultured enzyme-linked immunospot assay (ELISPOT) enhances detection of low HIV-specific immune responses in exposed seronegative individuals in Kenya

Bibliographic Details
Main Authors:	Anzala Omu, Mutua Gaudensia, Gichuki Charity, Muturi Margaret
Format:	Article
Language:	English
Published:	BMC 2006-12-01
Series:	Retrovirology

Similar Items

Use of enzyme linked immunospot assay (ELISpot) for monitoring treatment response of pulmonary tuberculosis patients
by: Ramadan M. Nafae, et al.
Published: (2013-07-01)

Characterization of Varicella-Zoster (VZV) Specific T Cell Response in Healthy Subjects and Transplanted Patients by Using Enzyme Linked Immunospot (ELISpot) Assays
by: Irene Cassaniti, et al.
Published: (2021-08-01)

Evaluation of IFN-γ Enzyme-linked Immunospot Assay (ELISPOT) as a First-line Test in the Diagnosis of Non-immediate Hypersensitivity to Amoxicillin and Penicillin
by: Lenka Sedláčková, et al.
Published: (2018-04-01)

Diagnosis of Tuberculosis by an Enzyme-Linked Immunospot Assay for Interferon-γ
by: Jann-Yuan Wang, et al.
Published: (2007-04-01)

Evaluation of EBV- and HCMV-Specific T Cell Responses in Systemic Lupus Erythematosus (SLE) Patients Using a Normalized Enzyme-Linked Immunospot (ELISPOT) Assay
by: Irene Cassaniti, et al.
Published: (2019-01-01)

Enumeration and Characterization of Human Memory T Cells by Enzyme-Linked Immunospot Assays
by: Sandra A. Calarota, et al.
Published: (2013-01-01)

Diagnostic Usefulness of an Enzyme-linked Immunospot Assay for Interferon-γ in Extrapulmonary Tuberculosis
by: Yin-Tzu Tsai, et al.
Published: (2011-07-01)

Use of Pleural Fluid Interferon-gamma Enzyme-linked Immunospot Assay in the Diagnosis of Pleural Tuberculosis
by: Tika Adilistya, et al.
Published: (2016-09-01)

A modified anthrax toxin-based enzyme-linked immunospot assay reveals robust T cell responses in symptomatic and asymptomatic Ebola virus exposed individuals.
by: Bobby Brooke Herrera, et al.
Published: (2018-05-01)

Recruitment and Follow Up of High Risk HIV Negative Volunteers in Preparation For Vaccine Trials, Kenyan Case
by: Odada Jane, et al.
Published: (2005-12-01)

Evaluation of an enzyme-linked immunospot assay for the immunodiagnosis of atypical spinal tuberculosis (atypical clinical presentation/atypical radiographic presentation) in China
by: Kai Yuan, et al.
Published: (2013-09-01)

Evaluation of an enzyme-linked immunospot assay for the immunodiagnosis of atypical spinal tuberculosis (atypical clinical presentation/atypical radiographic presentation) in China
by: Kai Yuan, et al.

Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya.
by: Borna A Nyaoke, et al.
Published: (2017-01-01)

Bronchoalveolar lavage enzyme-linked immunospot for diagnosis of smear-negative tuberculosis in HIV-infected patients.
by: Adithya Cattamanchi, et al.
Published: (2012-01-01)

Usefulness of BK virus-specific interferon-γ enzyme-linked immunospot assay for predicting the outcome of BK virus infection in kidney transplant recipients
by: Hyunjoo Bae, et al.
Published: (2021-01-01)

Blunted IL17/IL22 and pro-inflammatory cytokine responses in the genital tract and blood of HIV-exposed, seronegative female sex workers in Kenya.
by: Duncan Chege, et al.
Published: (2012-01-01)

ELISPOT Cell Analysis Assay: Searching for Extracellular Footprints
by: Alexander E. Kalyuzhny
Published: (2011-09-01)

Affinity Tag Coating Enables Reliable Detection of Antigen-Specific B Cells in Immunospot Assays
by: Sebastian Köppert, et al.
Published: (2021-07-01)

Utility of interferon-γ ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa
by: Ntobongwana Marjorie, et al.
Published: (2007-08-01)

The formulation of artificial reference standards for use within the ELISPOT assay
by: Bibi, Sagida
Published: (2013)

Development of an EliSPOT assay for detection of CMV-specific immune response
by: Maria Elena Terlizzi, et al.
Published: (2010-06-01)

Equivalence of ELISpot assays demonstrated between major HIV network laboratories.
by: Dilbinder K Gill, et al.
Published: (2010-12-01)

Stepping up ELISpot: Multi-Level Analysis in FluoroSpot Assays
by: Sylvia Janetzki, et al.
Published: (2014-11-01)

Role of ELISPOT Assays in Risk Assessment Pre- and Post-Kidney Transplantation
by: Anat R. Tambur, et al.
Published: (2012-05-01)

Dissecting the T Cell Response: Proliferation Assays vs. Cytokine Signatures by ELISPOT
by: Magdalena Tary-Lehmann, et al.
Published: (2012-05-01)

Using ELISPOT to expose false positive skin test conversion in tuberculosis contacts.
by: Philip C Hill, et al.
Published: (2007-01-01)

Acceptability and feasibility of repeated mucosal specimen collection in clinical trial participants in Kenya.
by: Gloria Omosa-Manyonyi, et al.
Published: (2014-01-01)

Willingness to participate in future HIV vaccine trials among men who have sex with men and female sex workers living in Nairobi, Kenya.
by: Elizabeth Mueni Mutisya, et al.
Published: (2020-01-01)

A novel rabbit immunospot array assay on a chip allows for the rapid generation of rabbit monoclonal antibodies with high affinity.
by: Tatsuhiko Ozawa, et al.
Published: (2012-01-01)

ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials
by: Thomas J. Sayers, et al.
Published: (2012-05-01)

An Enhanced ELISPOT Assay for Sensitive Detection of Antigen-Specific T Cell Responses to Borrelia burgdorferi
by: Gottfried H. Kellermann, et al.
Published: (2013-09-01)

Comparision of Tuberculin Skin Test and RD1-ELISPOT Assay in Health Care Workers
by: Ahmet SOYSAL, et al.
Published: (2005-09-01)

Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assay
by: Baseler Michael, et al.
Published: (2004-09-01)

The Granzyme B ELISPOT assay: an alternative to the <sup>51</sup>Cr-release assay for monitoring cell-mediated cytotoxicity
by: Baseler Michael, et al.
Published: (2003-12-01)

Bestimmung spenderreaktiver, IFNgamma-produzierender Zellen vor und nach Nierentransplantation im ELISpot-Assay
by: Presber, Franziska
Published: (2005)

Resting of Cryopreserved PBMC Does Not Generally Benefit the Performance of Antigen-Specific T Cell ELISPOT Assays
by: Ramu A. Subbramanian, et al.
Published: (2012-07-01)

Assessment of T-dependent and T-independent immune responses in cattle using a B cell ELISPOT assay
by: Grant Clare FJ, et al.
Published: (2012-10-01)

ELISPOT Assays in 384-Well Format: Up to 30 Data Points with One Million Cells
by: Jodi Hanson, et al.
Published: (2015-01-01)

A modified human ELISPOT assay to detect specific responses to primary tumor cell targets
by: Kwak Larry W, et al.
Published: (2004-03-01)

Evaluating the predictive performance of cytotoxic T lymphocyte epitope prediction tools using Elispot assay data
by: Meraba, Rebone Leboreng
Published: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gona64hbv01tn1ng5h6i5g7c4o